Medical/Pharmaceuticals
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner SK bioscience has received expanded manufacturing and marketing...
2023-01-18 21:00
2781
Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services
EAST RUTHERFORD, N.J., Jan. 18, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snap...
2023-01-18 19:00
2858
Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS
Newly merged organization brings together innovative neurodiagnostic and neuromonitoring solutions and experienced teams to offer a broader portfolio of products, services and support to customers worldwide. MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company"...
2023-01-18 18:03
3068
WFH Gene Therapy Registry: now live!
MONTREAL, Jan. 18, 2023 /PRNewswire/ -- To ensure patient safety remains at the forefront of the work of the World Federation of Hemophilia (WFH), we have developed a registry to monitor the long-term safety and efficacy of gene therapy for people with hemophilia: the WFH Gene Therapy Registry (G...
2023-01-18 18:00
2313
ASG Superconductors and Siemens Healthineers join forces to deliver 10.5T Ultra High Field MRI Systems for ground-breaking brain research
GENOA, Italy, Jan. 18, 2023 /PRNewswire/ -- ASG Superconductors (ASG) and
Siemens Healthineers signed a partnership agreement to synergistically develop
UHF MRI systems of unprecedented dependability for ground-breaking brain
research.
2023-01-18 18:00
3172
Docquity delivers 10% market share growth for Philippine-based pharmaceutical client in just one year
* Docquity's leading network of HCPs and proprietary Awareness to Advocacy (A2A) solution complemented the Client's Sales and Marketing team to increase conversions in a highly competitive pain product market * Client was able to grow prescriptions and revenue, with over 80% cost savings comp...
2023-01-18 10:00
3610
Boehringer Ingelheim Malaysia Honored As Top Employer For The Fifth Consecutive Year
* Boehringer Ingelheim is one of 15 global Top Employers worldwide * Achieved Global Recognition and Top Employer Certification in 29 countries From Top Employers Institute® * Outstanding employer benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition...
2023-01-18 09:00
2662
Boehringer Ingelheim Vietnam Honored As Top Employer For The Fourth Consecutive Year
HO CHI MINH CITY, Vietnam, Jan. 18, 2023 /PRNewswire/ -- Boehringer Ingelheim Vietnam has been honored for the fourth year in succession for its outstanding employee benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition. Globally, Boehringer Ingelheim has ...
2023-01-18 09:00
3293
Mental health focus makes Boehringer Ingelheim stand out as Top Employer 2023 in Asia Pacific for Third Consecutive Year
* Boehringer Ingelheim is one of 15 global Top Employers worldwide * Achieved Global Recognition and Top Employer Certification in 29 countries From Top Employers Institute® * Outstanding employer benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition S...
2023-01-18 09:00
2521
Telix Reports Fourth Quarter 2022 Financial Results
MELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ -- 18 January 2023. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended31 December 2022 (Q4 2022). All figures are in AUD$ ...
2023-01-18 08:50
3019
Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer
SUZHOU, China, Jan. 18, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that it will present t...
2023-01-18 08:00
2401
Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in China
Study findings suggest that EVER206 is well-tolerated with no new safety signals, supporting next-phase clinical development inChina SHANGHAI, Jan. 18, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest"), a biopharmaceutical company focused on the development, manufacturing and comm...
2023-01-18 07:30
3410
Suvoda 2022 Clinical Trials Surge 20% as it Expands Offerings to Include eConsent and eCOA
Company achieves Top Performer status in ISR IRT Benchmark Survey PHILADELPHIA, Jan. 18, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, surpassed 1...
2023-01-18 07:00
2091
Abbisko Therapeutics Obtains Approval from The China NMPA to Conduct a Phase II Clinical Study of Pimicotinib (ABSK021） in cGVHD
SHANGHAI, Jan. 18, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that its CSF-1R inhibitor, pimicotinib (ABSK021), has been approved by the National Medical Products Administration ("NMPA") of the People's Republic ofChina for a phase II c...
2023-01-18 07:00
2931
NOVARAD PROVIDES FREE DIGITAL HEALTH RECORD SHARING TECHNOLOGY TO HOSPITALS IN DEVELOPING COUNTRIES
CryptoChart Lite Medical Image Sharing System Provides Secure Medical Imaging and Digital Records Transfer via Secure QR Code or Web Access Code SALT LAKE CITY, Jan. 17, 2023 /PRNewswire/ -- Novarad announced today its release of CryptoChart Lite, a web-based version of the healthcare company's ...
2023-01-17 22:15
2352
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management
* LePure Biotech is a leading provider of high-quality and innovative single-use bioprocessing solutions inChina * Proceeds will be used to continue to accelerate product innovation and advance LePure Biotech's go-to-market strategy SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Shanghai LePure Biot...
2023-01-17 22:00
3013
Health in Transportation, NuraLogix Release New Smartphone Face-Scanning Application Aimed at Uncovering Life-Threatening Health Concerns in Professional Drivers
ST. GEORGE, Utah, Jan. 17, 2023 /PRNewswire/ -- Health in Transportation, a health and wellness solution provider for the transportation industry, has partnered with health technology giant NuraLogix to deliver a revolutionary preventative health tool for drivers called CDL Health Scanner. Acces...
2023-01-17 22:00
2097
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Shanghai LePure Biotech Co., Ltd. ("LePure") announced the completion of its Series C financing from a consortium of world-renowned investors co-led by Novo Holdings, General Atlantic and Goldman Sachs Asset Management, with participation from existing inve...
2023-01-17 20:41
3269
Accuray Announces First Patient Treatments in New Zealand With the CyberKnife® System, the World's Only Robotic Radiation Therapy Delivery Device
Auckland Radiation Oncology Selected the Latest-Generation CyberKnife S7™ System to Deliver Precise Treatments More Quickly, so Patients Can Rapidly Return to the Activities They Enjoy SUNNYVALE, Calif., Jan. 17, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Auckla...
2023-01-17 20:35
2154
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC
* World's first anti-PD-1 mAb for the first-line treatment of SCLC * Making a new record with the median OS of 15.8 months in an international, multi-center, phase 3 clinical trial * Granted orphan drug designations by the FDA and the EC, paving the way for international commercialization SH...
2023-01-17 19:42
2843
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 335 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 309 media titles]
2025-01-18 17:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 304 media titles]
2025-01-21 16:00
Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC
[Picked up by 290 media titles]
2025-01-20 21:09
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
10556
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
9593
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
9266
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
9156